Geoffrey White
J. Stewart White
Peter C. Wetherall
Michael T. Suglia
Melanie A. Ells
Of Counsel
Area of Practice
Truck Accidents Serious Personal Injury Auto Accidents Products Liability Medical Malpractice Medical Malpractice
Wrongful Death Vehicle Accidents Personal Injury Wrongful Death Premises Liability Defective Drugs / Medical Devices
Products Liability Birth Injury Elder Care Neglect Nursing Home Negligence Premises Liability Premises Liability

Johnson & Johnson Cypher Stent

Blood clotting (thrombosis) associated with drug coated heart stents like Johnson & Johnson's Cypher Stent, is four to five times more likely than with regular metal stents, according to a Cleveland Clinic study released November 29, 2006.  

If you are a patient with drug-eluting stents, you should contact us at White & Wetherall today to learn about your options and the available legal remedies. Call us for a free stent case review! Late thrombosis associated with stents following angioplasty can lead to heart attacks, stroke and death. 

The Cypher stent was approved by the DA in April 2003 and emits the drug Sirolimus, which is intended to solve the restenosis (reclosure) problem by inhibiting the overgrowth of the  endothelial cells in the blood vessels. The belief among a few health care professionals is that Sirolimus inhibits the creation of a protective coating that grows in the vessel around the stent to protect against clots.

 
LOCATIONS 

In Southern Nevada
9345 West Sunset Road Ste. 100
Las Vegas, Nevada 89148

In Northern Nevada
3185 Lakeside Dr.
Reno, Nevada 89509
QUESTIONNAIRE 
    Do you have a case? 
    Please answer a few 
    questions and one of our
    experienced trial attorneys
    will contact you with an
    answer.
    more »
© 2008 THE LAW OFFICES OF WHITE & WETHERALL